Related Experiment Video
Updated: Jul 18, 2026
10:45
Real-time Iontophoresis with Tetramethylammonium to Quantify Volume Fraction and Tortuosity of Brain Extracellular Space
Published on: July 24, 2017
Free phenytoin concentration measurement in brain extracellular fluid: a pilot study
1Department of Neuroanaesthesia and Neurocritical Care, National Hospital for Neurology and Neurosurgery, London, UK. martin.tisdall@uclh.nhs.uk
British Journal of Neurosurgery
|November 30, 2006
Summary
Plasma phenytoin levels may not accurately reflect brain concentrations in acute brain injury patients. Individual patient data showed correlation, but group data did not, suggesting dosing challenges.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Phenytoin is an antiepileptic drug commonly used in patients with acute brain injury.
- Accurate measurement of free phenytoin concentration in the brain extracellular fluid (ECF) is crucial for effective therapeutic dosing.
- Plasma free phenytoin concentration is often used as a surrogate for brain ECF free phenytoin concentration.
Purpose of the Study:
- To investigate the relationship between brain ECF free phenytoin concentration and plasma free phenytoin concentration in adults with acute brain injury.
- To determine if plasma free phenytoin levels can reliably predict brain ECF free phenytoin levels in this patient population.
Main Methods:
- Cerebral microdialysis was used to measure daily brain ECF free phenytoin concentration in eight adults with acute brain injury.
- Simultaneous plasma samples were collected for free phenytoin concentration measurement.
- In vitro microdialysis relative recovery for phenytoin was determined.
Main Results:
- Group analysis showed no significant correlation between brain ECF and plasma free phenytoin concentrations (r = 0.34, p = 0.41).
- However, significant intra-individual correlations were observed in two patients (r = 0.92, p < 0.001 and r = 0.88, p < 0.01).
- In vitro microdialysis relative recovery for phenytoin was 2.1%.
Conclusions:
- Plasma free phenytoin concentration may not accurately reflect brain ECF free phenytoin concentration in patients with acute brain injury.
- Current dosing regimens relying on plasma phenytoin levels may have limitations in achieving reproducible brain ECF concentrations.
- Further research is needed to optimize phenytoin dosing strategies in acute brain injury.
Related Concept Videos
01:23Drug Concentrations: Measurements
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Plasma —...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.